170 related articles for article (PubMed ID: 19710529)
1. Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico.
Lopez-Izquierdo A; Ponce-Balbuena D; Ferrer T; Sachse FB; Tristani-Firouzi M; Sanchez-Chapula JA
Cell Physiol Biochem; 2009; 24(3-4):153-60. PubMed ID: 19710529
[TBL] [Abstract][Full Text] [Related]
2. PA-6 inhibits inward rectifier currents carried by V93I and D172N gain-of-function K
Ji Y; Veldhuis MG; Zandvoort J; Romunde FL; Houtman MJC; Duran K; van Haaften G; Zangerl-Plessl EM; Takanari H; Stary-Weinzinger A; van der Heyden MAG
J Biomed Sci; 2017 Jul; 24(1):44. PubMed ID: 28711067
[TBL] [Abstract][Full Text] [Related]
3. Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome.
El Harchi A; McPate MJ; Zhang Yh; Zhang H; Hancox JC
J Mol Cell Cardiol; 2009 Nov; 47(5):743-7. PubMed ID: 19285083
[TBL] [Abstract][Full Text] [Related]
4. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene.
Priori SG; Pandit SV; Rivolta I; Berenfeld O; Ronchetti E; Dhamoon A; Napolitano C; Anumonwo J; di Barletta MR; Gudapakkam S; Bosi G; Stramba-Badiale M; Jalife J
Circ Res; 2005 Apr; 96(7):800-7. PubMed ID: 15761194
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the Effects of the Short QT Syndrome D172N Kir2.1 Mutation on Ventricular Action Potential Profile Using Dynamic Clamp.
Du C; Rasmusson RL; Bett GC; Franks B; Zhang H; Hancox JC
Front Pharmacol; 2021; 12():794620. PubMed ID: 35115940
[TBL] [Abstract][Full Text] [Related]
6. Proarrhythmia in KCNJ2-linked short QT syndrome: insights from modelling.
Adeniran I; El Harchi A; Hancox JC; Zhang H
Cardiovasc Res; 2012 Apr; 94(1):66-76. PubMed ID: 22308236
[TBL] [Abstract][Full Text] [Related]
7. Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.
Luo C; Wang K; Zhang H
Physiol Meas; 2017 Sep; 38(10):1859-1873. PubMed ID: 28812984
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.
Ponce-Balbuena D; López-Izquierdo A; Ferrer T; Rodríguez-Menchaca AA; Aréchiga-Figueroa IA; Sánchez-Chapula JA
J Pharmacol Exp Ther; 2009 Nov; 331(2):563-73. PubMed ID: 19654266
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel.
Rodríguez-Menchaca AA; Navarro-Polanco RA; Ferrer-Villada T; Rupp J; Sachse FB; Tristani-Firouzi M; Sánchez-Chapula JA
Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1364-8. PubMed ID: 18216262
[TBL] [Abstract][Full Text] [Related]
10. Styrax blocks inward and outward current of Kir2.1 channel.
Ren S; Pang C; Li J; Huang Y; Zhang S; Zhan Y; An H
Channels (Austin); 2017 Jan; 11(1):46-54. PubMed ID: 27540685
[TBL] [Abstract][Full Text] [Related]
11. Low-affinity spermine block mediating outward currents through Kir2.1 and Kir2.2 inward rectifier potassium channels.
Ishihara K; Yan DH
J Physiol; 2007 Sep; 583(Pt 3):891-908. PubMed ID: 17640933
[TBL] [Abstract][Full Text] [Related]
12. Ser165 in the second transmembrane region of the Kir2.1 channel determines its susceptibility to blockade by intracellular Mg2+.
Fujiwara Y; Kubo Y
J Gen Physiol; 2002 Nov; 120(5):677-93. PubMed ID: 12407079
[TBL] [Abstract][Full Text] [Related]
13. Voltage-dependent gating and block by internal spermine of the murine inwardly rectifying K+ channel, Kir2.1.
Matsuda H; Oishi K; Omori K
J Physiol; 2003 Apr; 548(Pt 2):361-71. PubMed ID: 12640008
[TBL] [Abstract][Full Text] [Related]
14. Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.
Luo C; Wang K; Zhang H
Biomed Eng Online; 2017 Jun; 16(1):69. PubMed ID: 28592292
[TBL] [Abstract][Full Text] [Related]
15. Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria.
Whittaker DG; Ni H; El Harchi A; Hancox JC; Zhang H
PLoS Comput Biol; 2017 Jun; 13(6):e1005593. PubMed ID: 28609477
[TBL] [Abstract][Full Text] [Related]
16. Efficient and specific cardiac IK₁ inhibition by a new pentamidine analogue.
Takanari H; Nalos L; Stary-Weinzinger A; de Git KC; Varkevisser R; Linder T; Houtman MJ; Peschar M; de Boer TP; Tidwell RR; Rook MB; Vos MA; van der Heyden MA
Cardiovasc Res; 2013 Jul; 99(1):203-14. PubMed ID: 23625347
[TBL] [Abstract][Full Text] [Related]
17. Modelling the effects of chloroquine on
Luo C; Wang K; Zhang H
Oncotarget; 2017 Dec; 8(63):106511-106526. PubMed ID: 29290967
[TBL] [Abstract][Full Text] [Related]
18. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents.
Hattori T; Makiyama T; Akao M; Ehara E; Ohno S; Iguchi M; Nishio Y; Sasaki K; Itoh H; Yokode M; Kita T; Horie M; Kimura T
Cardiovasc Res; 2012 Mar; 93(4):666-73. PubMed ID: 22155372
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Kir2.1 and Na
Ponce-Balbuena D; Guerrero-Serna G; Valdivia CR; Caballero R; Diez-Guerra FJ; Jiménez-Vázquez EN; Ramírez RJ; Monteiro da Rocha A; Herron TJ; Campbell KF; Willis BC; Alvarado FJ; Zarzoso M; Kaur K; Pérez-Hernández M; Matamoros M; Valdivia HH; Delpón E; Jalife J
Circ Res; 2018 May; 122(11):1501-1516. PubMed ID: 29514831
[TBL] [Abstract][Full Text] [Related]
20. Inward Rectifier Potassium Channels (Kir2.x) and Caveolin-3 Domain-Specific Interaction: Implications for Purkinje Cell-Dependent Ventricular Arrhythmias.
Vaidyanathan R; Van Ert H; Haq KT; Morotti S; Esch S; McCune EC; Grandi E; Eckhardt LL
Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005800. PubMed ID: 29326130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
